PomegraSurgery Partners Stock Jumps 47.6% After $5.7B Buyout
Why did Surgery Partners stock jump 47.6%?
Surgery Partners (SGRY) stock jumped 47.6% to $23.25 on Monday after a Bon Secours Mercy Health affiliate agreed to buy it for $23.50 a share in cash, a $5.7B deal including debt.
Key numbers
| Offer price | $23.50+49% vs Friday close |
|---|---|
| Monday close | $23.25+47.62% (up 46% earlier in the day) |
| Deal value (incl. debt) | $5.7Benterprise value |
| Bain Capital stake | ~39%rolled into buyer |
| Expected close | Q1 2027needs shareholder and regulatory approval |
What happened
Surgery Partners (SGRY) stock jumped 47.6% to $23.25 on Monday after a Bon Secours Mercy Health affiliate agreed to buy it for $23.50 a share in cash, a $5.7B deal including debt. The offer is 49% above Friday's $15.75 close, and the buyer is HealthSpan Partners, part of the Bon Secours Mercy Health hospital system. Bain Capital, which owns about 39%, will swap its shares for a stake in the buyer instead of cashing out. Shares closing just under the offer price suggests investors expect the deal to finish, which is planned for early 2027.
Why it matters
Surgery Partners runs more than 200 locations across 30 US states, including surgery centers and surgical hospitals, and it will leave the stock market if the deal closes. Shareholders will get a fixed cash price instead of owning shares that rise and fall. The deal also shows a hospital system paying to expand into surgery done outside hospitals, while the company keeps its name, brand and headquarters.
Who this affects
- MarketneutralLow impact
- Little broad-market effect; Surgery Partners holders gain most.
- CompanybullishHigh impact
- Shareholders get cash at a 49% premium; company goes private.
- CompetitorsneutralLow impact
- Tenet barely moved, HCA slipped less than 1%.
- IndustryneutralMedium impact
- Shows hospital systems want more outpatient surgery businesses.
Surgery Partners vs Tenet Healthcare, HCA Healthcare
How we got here
Surgery Partners closes at $15.75 before the deal is announced.
HealthSpan Partners announces $23.50 cash deal; shares close at $23.25.
An investor rights firm says it is investigating whether the price is fair to shareholders.
What to watch
- Surgery Partners shareholder vote and regulatory approvals needed to close the deal.Q1 2027
- Whether shares stay just under $23.50, signaling confidence the deal will close.Q1 2027
Educational content only. Not investment advice.
More briefsAll briefs →
Jio Platforms Shares Set for 22% Debut Jump After IPO
Reliance Industries (RELIANCE:NSE) unit Jio lists Oct. 28 after a ₹30,200 crore IPO bid for 22 times over.
Ross Stores Stock Rises 2.1% After UBS Upgrade
Ross Stores (ROST) ended Monday higher as UBS set a $315 price target on stronger sales per store.
Canada Tariffs Stay at 50% as Trump Predicts Trade Deal 'Soon'
The TSX (^GSPTSE) closed Friday at 35,788 as Canada signals no deal before the Nov. 3 US midterm elections.